News

Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
HIMS stock plunges as Novo Nordisk severs ties with Hims & Hers over Wegovy sales
Novo Nordisk ends partnership with Hims & Hers over safety and marketing concerns tied to compounded Wegovy, as rivalry with ...
When Could Eli Lilly’s Weight Loss Pill Hit the Market?
A new injectable weight loss treatment from the maker of Ozempic and Wegovy delivered 23% weight loss in trials, according to ...
Mounjaro went head-to-head against Wegovy with one clear winner as the new 'weight loss jab' to be rolled out across UK
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...
Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
Zacks Investment Research on MSN4d
What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?
Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.
The Pharma Letter3d
High-dose Wegovy cuts weight 21%, new data shows
At a time when Novo Nordisk has appeared to be slipping behind rival Eli Lilly and its blockbuster Zepbound (tirzepatide) in ...